🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

469 notícias encontradas para "stock"
Stocks have more upside, S&P 500 seen at 7,900, UBS says
A pauta traz uma atualização relevante e serve como base para a cobertura editorial. O recorte ajuda a contextualizar a pauta dentro de Finanças.
Abm Industries SVP Dean Chin sells $179,346 in stock
Abm Industries SVP Dean Chin sells $179,346 in stock
A pauta traz uma atualização relevante e serve como base para a cobertura editorial. O recorte ajuda a contextualizar a pauta dentro de Economia.
D.A. Davidson reiterates Unity Bancorp stock rating on loan growth
D.A. Davidson reiterates Unity Bancorp stock rating on loan growth
A pauta traz uma atualização relevante e serve como base para a cobertura editorial. O recorte ajuda a contextualizar a pauta dentro de Economia.
Repay stock holds Buy rating at DA Davidson after board rejects bid
Repay stock holds Buy rating at DA Davidson after board rejects bid
A pauta traz uma atualização relevante e serve como base para a cobertura editorial. O recorte ajuda a contextualizar a pauta dentro de Economia.
DA Davidson reiterates Fastenal stock rating on margin pressure
DA Davidson reiterates Fastenal stock rating on margin pressure
A pauta traz uma atualização relevante e serve como base para a cobertura editorial. O recorte ajuda a contextualizar a pauta dentro de Economia.
‘Thunder Road’: Atriz de ‘Fear the Walking Dead’ é escalada para o novo drama sobre corrid
‘Thunder Road’: Atriz de ‘Fear the Walking Dead’ é escalada para o novo drama sobre corrid
Segundo o Deadline, Maggie Grace (‘Fear the Walking Dead’) foi escalada para o elenco de ‘Thunder Road’, nova série de drama criada por John Fusco (‘Marco Polo’). A atriz se junta aos previamente anunciados Dennis Quaid (‘O Dia Depois do Amanhã’), Chase Stokes (‘Outer Banks’), Mi
This Wall Street ‘theme-o-meter’ has a clear message: The artificial-intelligence bull mar
This Wall Street ‘theme-o-meter’ has a clear message: The artificial-intelligence bull mar
UBS says its top theme right now is that leadership for artificial-intelligence stocks is returning, and earnings season may prove how investors have been too pessimistic.
As the US restarts war on Iran, is its weapons stockpile running low?
The US has expended a significant number of munitions since the war began in February. O recorte ajuda a contextualizar a pauta dentro de Geral.
Technical details need to be agreed before Ukraine can produce Patriot missiles, Zelensky
Technical details need to be agreed before Ukraine can produce Patriot missiles, Zelensky
Ukraine's President Volodymyr Zelensky on Thursday said that technical details still needed to be finalised with the US before Kyiv could start manufacturing its own Patriot air-defence missiles. Ukraine's dwindling interceptor stockpiles have been outstripped by Russia's deadly
New blood test detects more high-risk prostate cancer cases
New blood test detects more high-risk prostate cancer cases
A new blood test may make it easier to detect the most dangerous forms of prostate cancer early. In a study from Karolinska Institutet, the Stockholm3 blood test detected more clinically significant cancer cases than the PSA test, without subjecting more men to unnecessary testin
Declining global acceptability of intimate partner violence tied to declining prevalence
Declining global acceptability of intimate partner violence tied to declining prevalence
A study of more than 60 countries shows those with faster declines in the social acceptability of intimate partner violence against women also tend to have had faster reductions in rates of such violence, as well as faster human development improvements. Irina Vartanova of the In
EHA: Adding Pirtobrutinib to Venetoclax-Rituximab ups progression-free survival in chronic
For patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL), adding pirtobrutinib to venetoclax-rituximab (PVR) yields improved progression-free survival (PFS) compared to venetoclax-rituximab (VR), according to a study presented at the annual congress of the E